OpGen, Inc. (OPGN) Financials
OPGN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 18.1 million | 15.5 million |
2023-06-30 | 22.4 million | 15.6 million |
2023-03-31 | 26.5 million | 17.3 million |
2022-12-31 | 25.8 million | 18.3 million |
OPGN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -3.0 million | -229483 |
2023-06-30 | -5.1 million | 156529 |
2023-03-31 | -5.3 million | 211122 |
2022-12-31 | -4.4 million | 223546 |
OPGN Net Income
No data available :(
OPGN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 292642 | - | 3.4 million |
2023-06-30 | 3.2 million | - | 3.5 million |
2023-03-31 | 7.0 million | - | 3.6 million |
2022-12-31 | 7.4 million | - | 2.9 million |
OPGN Shares Outstanding
OPGN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 101737 | 1.2 million | 2.0 million | 336184 |
2023-06-30 | 367315 | 1.4 million | 2.4 million | 1.2 million |
2023-03-31 | 330446 | 1.8 million | 2.4 million | 1.0 million |
2022-12-31 | 404216 | 1.6 million | 2.1 million | 1.1 million |
OPGN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 699022 | 691970 |
2023-06-30 | 736137 | 918494 |
2023-03-31 | 913444 | 720684 |
2022-12-31 | 721630 | 535964 |
OPGN
Price: $0.40
52 week price:
Earnings Per Share: -6.25 USD
P/E Ratio: -0.05
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 232100
Ebitda: -3.0 millionMarket Capitalization: 8.2 million